TRVLX | VIVIX | TRVLX / VIVIX | |
Total Expense Ratio | 0.69 | 0.04 | 1,725% |
Annual Report Gross Expense Ratio | 0.70 | 0.04 | 1,750% |
Fund Existence | 31 years | 27 years | - |
Gain YTD | 7.515 | 6.533 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 30B | 196B | 15% |
Annual Yield % from dividends | 1.14 | 2.19 | 52% |
Returns for 1 year | 1.54 | 7.91 | 19% |
Returns for 3 years | 12.12 | 25.93 | 47% |
Returns for 5 years | 39.73 | 68.54 | 58% |
Returns for 10 years | 49.74 | 114.61 | 43% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 27.27 | 0.19 | +0.72% |
F/m Emerald Life Sciences Innovation ETF | |||
XLRE | 41.33 | 0.27 | +0.66% |
The Real Estate Select Sector SPDR® | |||
ULST | 40.60 | 0.02 | +0.04% |
SPDR® SSgA Ultra Short Term Bond ETF | |||
HYDW | 47.15 | 0.02 | +0.04% |
Xtrackers Low Beta High Yield Bond ETF | |||
IBIB | 25.37 | 0.01 | +0.04% |
iShares iBonds Oct 2025 Term Tips ETF |